BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31503200)

  • 1. A Review of Two Heparin Prophylaxes for Trauma.
    Yu HD
    J Trauma Nurs; 2019; 26(5):263-269. PubMed ID: 31503200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
    J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of low molecular weight heparin and low dose unfractionated heparin prophylaxis in subacute myelopathy.
    Spivack SB; Aisen ML
    J Spinal Cord Med; 1997 Oct; 20(4):402-5. PubMed ID: 9360220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of heparin therapy for preventing venous thromboembolism in acute spinal cord injury.
    Liu Y; Xu H; Liu F; Lv Z; Kan S; Ning G; Feng S
    Int J Surg; 2017 Jul; 43():94-100. PubMed ID: 28579397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort study.
    Worley S; Short C; Pike J; Anderson D; Douglas JA; Thompson K
    J Spinal Cord Med; 2008; 31(4):379-87. PubMed ID: 18959355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Geerts WH; Pineo GF; Heit JA; Bergqvist D; Lassen MR; Colwell CW; Ray JG
    Chest; 2004 Sep; 126(3 Suppl):338S-400S. PubMed ID: 15383478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.
    Fowler RA; Mittmann N; Geerts W; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
    JAMA; 2014 Nov; 312(20):2135-45. PubMed ID: 25362228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative prophylaxis of venous thromboembolism (VTE) in patients undergoing high ligation and stripping of the great saphenous vein (GSV).
    Wang H; Sun Z; Jiang W; Zhang Y; Li X; Wu Y
    Vasc Med; 2015 Apr; 20(2):117-21. PubMed ID: 25601917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tale of two centers: Is low-molecular-weight heparin really superior for prevention of posttraumatic venous thromboembolism?
    Checchi KD; Costantini TW; Badiee J; Berndtson AE; Calvo RY; Rooney AS; Wessels LE; Prieto JM; Sise CB; Sise MJ; Martin MJ; Bansal V
    J Trauma Acute Care Surg; 2021 Sep; 91(3):537-541. PubMed ID: 33901051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboprophylaxis for trauma patients.
    Barrera LM; Perel P; Ker K; Cirocchi R; Farinella E; Morales Uribe CH
    Cochrane Database Syst Rev; 2013 Mar; (3):CD008303. PubMed ID: 23543562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism prophylaxis in patients undergoing cranial neurosurgery: a systematic review and meta-analysis.
    Hamilton MG; Yee WH; Hull RD; Ghali WA
    Neurosurgery; 2011 Mar; 68(3):571-81. PubMed ID: 21311292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Rasmussen MS; Jørgensen LN; Wille-Jørgensen P
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin for venous thromboembolism prophylaxis in patients with acute spinal cord injury: a systematic review and meta-analysis.
    Chen HL; Wang XD
    Spinal Cord; 2013 Aug; 51(8):596-602. PubMed ID: 23689387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the impact of culture on venous thromboembolism prevention in trauma patients: A Southwestern Surgical Congress Multicenter trial.
    Regner JL; Shaver CN;
    Am J Surg; 2019 Jun; 217(6):1030-1036. PubMed ID: 30503515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
    Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
    Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of dalteparin versus unfractionated heparin as venous thromboembolism prophylaxis in malignant gynecologic surgery.
    Wade WE; Spruill WJ
    Am J Ther; 2008; 15(6):512-5. PubMed ID: 19127133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
    Venet C; Berger C; Tardy B; Viallon A; Decousus H; Bertrand JC
    Presse Med; 2000 Jan; 29(2):68-75. PubMed ID: 10682030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.